285 related articles for article (PubMed ID: 16163136)
21. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
Schöder H; Carlson DL; Kraus DH; Stambuk HE; Gönen M; Erdi YE; Yeung HW; Huvos AG; Shah JP; Larson SM; Wong RJ
J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
[TBL] [Abstract][Full Text] [Related]
22. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
23. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
24. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
25. Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patients.
Römer W; Nömayr A; Greess H; Fiedler E; Platsch G; Schuler-Thurner B; Pfahlberg A; Hothorn T; Schuler G; Hornegger J; Bautz W; Kuwert T
Nuklearmedizin; 2006; 45(2):88-95. PubMed ID: 16547570
[TBL] [Abstract][Full Text] [Related]
26. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
27. The impact of FDG-PET/CT on the management of head and neck tumours: the radiotherapist's perspective.
Dietl B; Marienhagen J; Kühnel T; Schreyer A; Kölbl O
Oral Oncol; 2008 May; 44(5):504-8. PubMed ID: 17826307
[TBL] [Abstract][Full Text] [Related]
28. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
29. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.
Bassi MC; Turri L; Sacchetti G; Loi G; Cannillo B; La Mattina P; Brambilla M; Inglese E; Krengli M
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1423-6. PubMed ID: 17931795
[TBL] [Abstract][Full Text] [Related]
30. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
[TBL] [Abstract][Full Text] [Related]
31. [Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].
Di Martino E; Nowak B; Krombach GA; Sellhaus B; Hausmann R; Cremerius U; Büll U; Westhofen M
Laryngorhinootologie; 2000 Apr; 79(4):201-6. PubMed ID: 10838683
[TBL] [Abstract][Full Text] [Related]
32. Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum.
Nettelbladt OS; Sundin AE; Valind SO; Gustafsson GR; Lamberg K; Långström B; Björnsson EH
J Nucl Med; 1998 Apr; 39(4):640-7. PubMed ID: 9544671
[TBL] [Abstract][Full Text] [Related]
33. Value of retrospective image fusion of ¹⁸F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI.
Kanda T; Kitajima K; Suenaga Y; Konishi J; Sasaki R; Morimoto K; Saito M; Otsuki N; Nibu K; Sugimura K
Eur J Radiol; 2013 Nov; 82(11):2005-10. PubMed ID: 23891295
[TBL] [Abstract][Full Text] [Related]
34. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
[TBL] [Abstract][Full Text] [Related]
35. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
[TBL] [Abstract][Full Text] [Related]
36. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
37. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion.
Schöder H; Yeung HW; Gonen M; Kraus D; Larson SM
Radiology; 2004 Apr; 231(1):65-72. PubMed ID: 14990824
[TBL] [Abstract][Full Text] [Related]
38. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Strobel K; Dummer R; Husarik DB; Pérez Lago M; Hany TF; Steinert HC
Radiology; 2007 Aug; 244(2):566-74. PubMed ID: 17641374
[TBL] [Abstract][Full Text] [Related]
39. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
[TBL] [Abstract][Full Text] [Related]
40. Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.
Picchio M; Treiber U; Beer AJ; Metz S; Bössner P; van Randenborgh H; Paul R; Weirich G; Souvatzoglou M; Hartung R; Schwaiger M; Piert M
J Nucl Med; 2006 Jun; 47(6):938-44. PubMed ID: 16741302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
